Article info

Original research
Radiological dynamics and SITC-defined resistance types of advanced melanoma during anti-PD-1 monotherapy: an independent single-blind observational study on an international cohort

Authors

  • Xue Bai Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education, Beijing), Department of Renal Cancer and Melanoma, Peking University Cancer Hospital and Institute, Beijing, ChinaMassachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts, USA PubMed articlesGoogle scholar articles
  • Michelle Kim Department of Surgical Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA PubMed articlesGoogle scholar articles
  • Gyulnara Kasumova Department of Surgical Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA PubMed articlesGoogle scholar articles
  • Lu Si Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education, Beijing), Department of Renal Cancer and Melanoma, Peking University Cancer Hospital and Institute, Beijing, China PubMed articlesGoogle scholar articles
  • Bixia Tang Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education, Beijing), Department of Renal Cancer and Melanoma, Peking University Cancer Hospital and Institute, Beijing, China PubMed articlesGoogle scholar articles
  • Chuanliang Cui Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education, Beijing), Department of Renal Cancer and Melanoma, Peking University Cancer Hospital and Institute, Beijing, China PubMed articlesGoogle scholar articles
  • Xiaoling Yang Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education, Beijing), Department of Renal Cancer and Melanoma, Peking University Cancer Hospital and Institute, Beijing, ChinaDepartment of Medical Oncology, Shanxi Bethune Hospital, Taiyuan, China PubMed articlesGoogle scholar articles
  • Xiaoting Wei Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education, Beijing), Department of Renal Cancer and Melanoma, Peking University Cancer Hospital and Institute, Beijing, China PubMed articlesGoogle scholar articles
  • Justine Cohen Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts, USAAbramson Cancer Center, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA PubMed articlesGoogle scholar articles
  • Donald Lawrence Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts, USA PubMed articlesGoogle scholar articles
  • Christine Freedman Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts, USA PubMed articlesGoogle scholar articles
  • Riley Fadden Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts, USA PubMed articlesGoogle scholar articles
  • Krista Rubin Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts, USA PubMed articlesGoogle scholar articles
  • Tatyana Sharova Department of Surgical Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA PubMed articlesGoogle scholar articles
  • Dennie Frederick Department of Surgical Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA PubMed articlesGoogle scholar articles
  • Keith Flaherty Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts, USA PubMed articlesGoogle scholar articles
  • Ryan Sullivan Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts, USA PubMed articlesGoogle scholar articles
  • Jun Guo Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education, Beijing), Department of Renal Cancer and Melanoma, Peking University Cancer Hospital and Institute, Beijing, China PubMed articlesGoogle scholar articles
  • Genevieve Boland Department of Surgical Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Jun Guo; guoj307{at}126.com; Dr Genevieve Boland; gmboland{at}partners.org
View Full Text

Citation

Bai X, Kim M, Kasumova G, et al
Radiological dynamics and SITC-defined resistance types of advanced melanoma during anti-PD-1 monotherapy: an independent single-blind observational study on an international cohort

Publication history

  • Accepted January 17, 2021
  • First published February 25, 2021.
Online issue publication 
January 26, 2023

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.